...Jiashen Cai; Dorothy Huang; Hanis Binte Abdul Kadir; Zhihua Huang; Li Choo Ng; Andrew Ang; Ngiap Chuan Tan; Yong Mong Bee; Wei Yi Tay; Chieh Suai Tan; Cynthia C. Lim Aims: Hospital readmissions due to recurrent fluid overload in diabetes and diabetic kidney disease can be avoided with evidence...

...Vårin Vinje; Tobias Bomholt; Peter Rossing; Carsten Lundby; Peter Oturai; Mads Hornum Background: Sodium-glucose cotransporter 2 (SGLT2) inhibitors exert a kidney protective effect in patients with diabetic kidney disease. Several mechanisms have been proposed, but why precisely SGLT2 inhibition...

... to the advanced ages, their glomerular filtration rates (GFR) decrease, and the comorbidities such as hypertension, diabetic condition, and obesity are common. The clinicians now have to give their unwilling consent to the LKT from the donors with expanded criteria. Summary: For the secure selection of donors...

... Sosa; Manuel Macia; Elena Terán García; Alejandra Álvarez González; Ana González Rinne; Aurelio Rodríguez; Eduardo De Bonis Redondo; Concepción Rodríguez Adanero; Domingo Hernández; Armando Torres Ramírez; Esteban Porrini Introduction: Inflammation is a risk factor for diabetes in the general...

... to in the content or advertisements. 2022 Bullous pemphigoid Gliptins DPP4 inhibitors Diabetes Chronic kidney disease Orally administered dipeptidyl peptidase-4 (DPP4) inhibitors (gliptins) are commonly used in the treatment of diabetic patients with stage 3–5 chronic kidney disease (CKD...

... or hypoglycemia. Summary: In non-dialysis patients with type 1 and type 2 diabetes, CGM metrics are increasingly used to estimate glycemic control and are associated with improvements in glucose levels. Although a clear link has not yet been established between some CGM variables and the development of late...

...Tobias Bomholt; Therese Adrian; Kirsten Nørgaard; Ajenthen G. Ranjan; Thomas Almdal; Anders Larsson; Mette Vadstrup; Marianne Rix; Bo Feldt-Rasmussen; Mads Hornum Background: Glycated haemoglobin A 1c (HbA 1c ) has limitations as a glycemic marker for patients with diabetes and CKD and for those...

...Louise Cox; Esther Wong; Katharine M. Evans; James Medcalf; Rhodri Pyart Introduction: Diabetes is a major cause of CKD and of mortality in patients on renal replacement therapy (RRT). Auditing the care of patients with diabetes on RRT against published guidelines relies on robust data collection...

...Rosa E. Pérez-Morales; María Dolores del Pino; José Manuel Valdivielso; Alberto Ortiz; Carmen Mora-Fernández; Juan F. Navarro-González Background: Diabetes is a growing public health problem. Diabetic kidney disease (DKD) is the most prevalent chronic renal disease and the major cause of end-stage...

... to disease severity in type 2 diabetes. Aim: In the current study we assess Grx as a potential clinical marker of oxidative stress in CKD. Methods: We examined Grx activity in 25 patients with different stages of chronic kidney failure, 19 control subjects, and 36 patients at initiation of dialysis and after...

... kg/m 2 ); government (1.22 [1.15–1.31]) vs. private housing; and with hypertension (3.32 [3.09–3.56]), diabetes (6.93 [6.67–7.20]) or stroke (1.46 [1.36–1.56]) vs. without each co-morbidity, respectively. The area under the receiver operating characteristic curve (95% CI) for the model to predict...

...Robert D. Toto Diabetic nephropathy is the leading cause of kidney failure. Treatments with drugs that block the renin-angiotensin system have proven beneficial in slowing kidney disease progression among those with diabetes; their benefit is limited and they do not stop disease progression...

...Vikram Thakur; Syeda Nargis; Mayra Gonzalez; Swetak Pradhan; Daniel Terreros; Munmun Chattopadhyay Background: Diabetic kidney disease (DKD) is one of the most debilitating complications of type 2 diabetes. Recent evidence suggests chronic inflammation to be one of the causal factors of DKD...

...Roberto Trevisan; Alessandro Roberto Dodesini Hyperfiltering kidney is a typical feature of diabetes. Improvement observed with regard to glucose control and blood pressure control reduces the high glomerular filtration rate and may contribute to retard the appearance and the progression...

...Radovan Hojs; Robert Ekart; Sebastjan Bevc; Nina Hojs The prevalence of diabetes is increasing and has already reached pandemic proportions. Diabetes is a well-known risk factor for chronic kidney disease. Diabetic kidney disease (DKD) occurs in up to 40% of people with type 1 or 2 diabetes...

...Eirini Lioudaki; Konstantinos G. Stylianou; Ioannis Petrakis; Georgios Kokologiannakis; Andreas Passam; Dimitri P. Mikhailidis; Eugene K. Daphnis; Emmanouil S. Ganotakis Background: Podocyte injury plays a crucial role in the pathogenesis and progression of diabetic nephropathy (DN). We...

... diabetes, cardiovascular disease and chronic kidney disease (CKD). Although AGEs were originally thought to form only endogenously, primarily as the result of the hyperglycemia of diabetes, it is now clear that exogenous AGEs, specially incorporated in foods, are an important contributor to the body pool...

...José B.Lopes de Faria; Rogério Friedman; Salvatore de Cosmo; Rosemary A. Dodds; James J. Mortton; GianCarlo Viberti Insulin-dependent diabetes mellitus (IDDM) patients may have an increased intrarenal angiotensin II activity. In diabetic patients, captopril increases the renal hemodynamic response...

...Sonoo Mizuiri; Miyuki Kobayashi; Tsutomu Nakanishi; Hiroko Yoshikawa; Moriatsu Miyagi; Masateru Tanegashima; Ken Sakai; Ikuko Hayashi; Tatsuo Fushimi; Akira Hasegawa Recent evidence suggests a role of angiotensin-converting enzyme (ACE) in diabetic nephropathy. The effect of diabetes and low...

... with an excellent renal function, 44 hypertensive patients, 30 type II diabetics, 29 cases of chronic graft dysfunction, 28 cases during an episode of acute rejection. RI was measured in three different renal vascular areas: prerenal, interlobar and cortical. A two-way analysis of variance showed a statistical...